Find uplifting stories about heroes, innovations, and solutions
6907 results for "antibody treatment"
Americans exposed to Ebola in Central Africa will now have access to a promising antibody treatment that has shown remarkable success in animal studies. The therapy offers new hope for protecting healthcare workers and others at risk during the current outbreak.
Scientists have discovered an antibody that successfully halted triple-negative breast cancer in laboratory models, offering hope for one of the most difficult cancers to treat. This breakthrough could lead to better treatment options for thousands of women facing this aggressive disease.
Researchers at the University of Southampton engineered a new four-pronged antibody that supercharges the immune system's ability to destroy cancer cells. The breakthrough could help millions of patients whose cancers don't respond to current treatments.
Researchers have discovered human antibodies that can prevent and treat measles, offering hope for millions who can't receive vaccines. The breakthrough treatment reduced viral loads 500-fold in early testing.
Scientists at UT Southwestern developed an antibody that shrank resistant lung tumors in lab tests, opening hope for patients who run out of options. The treatment worked even against cancers that stopped responding to existing drugs.
A migraine prevention drug just passed a major test for patients who haven't found relief from existing treatments. After 12 weeks, the intravenous antibody significantly reduced monthly migraine days compared to placebo.
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
Women with triple-negative breast cancer just gained two powerful new treatment options that work better than standard chemotherapy at keeping the disease under control. The FDA approved Trodelvy alone and combined with immunotherapy as first-line treatments for this aggressive cancer type.
A groundbreaking cancer treatment just gave patients with hard-to-treat lung cancer something they desperately needed: hope. Chinese biotech company Akeso's new drug ivonescimab beat the current standard treatment in a major clinical trial, marking a historic win for patients with limited options.
Four promising new treatments could reach patients this spring, offering fresh hope for people battling hard-to-treat conditions. From the first-ever medication for a chronic liver infection to an at-home Alzheimer's treatment, these therapies represent real progress for patients who've been waiting.
A Shanghai neurologist discovered a potential Alzheimer's therapy after his 90-year-old mother improved cognitively following ultrasound treatment for a different condition. His trial now tests high-intensity focused ultrasound as a standalone treatment, a promising departure from mainstream research.
A groundbreaking study will use advanced imaging to personalize cancer treatment, potentially cutting unnecessary therapy while helping more patients access care. The collaboration could transform how doctors decide when prostate cancer patients have received enough treatment.
For the first time in decades, Americans with treatment-resistant depression have two powerful new options that work differently than anything before. Clinical trials show these breakthrough treatments are helping patients who've struggled for years finally find relief.
UK scientists created a simple blood test that tells doctors whether breast cancer treatment will work before therapy even begins. The breakthrough could spare patients from months of ineffective drugs and help them find treatments that actually work.
Patients with chronic lymphocytic leukemia now have a new treatment option that doesn't require chemotherapy and allows time off from treatment. The FDA approved the first all-oral, fixed-duration therapy for this common adult leukemia.
Scientists have enrolled the first patient in a groundbreaking trial to find effective treatments for the deadly Bundibugyo strain of Ebola in the Democratic Republic of Congo. The trial brings hope to a region where more than 1,400 people have been infected since May, with currently no approved treatments available.
BestCare Treatment Services broke ground on Oregon's only residential treatment center designed specifically for Latino men struggling with substance use disorder. The culturally tailored facility will provide care entirely in Spanish, addressing critical language and cultural barriers that often prevent people from seeking help.
The FDA is accelerating reviews of three psychedelic medications for depression and PTSD, moving promising mental health treatments closer to patients who desperately need them. Millions struggling with treatment-resistant conditions could soon have groundbreaking new options.
Men with spreading prostate cancer can now postpone harsh hormone therapy for over two years thanks to a targeted radiation treatment that leaves healthy tissue untouched. A quarter of patients showed no tumors after treatment.
Showing 20 of 6907